Request Free Sample
×
Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market
ID: MRFR/HC/35356-HCR
100 Pages
October 2025
Informe de investigación de mercado sobre tratamiento de la deficiencia de transaminasas de ácido gamma-aminobutírico por tipo de tratamiento (medicación, terapia génica, control dietético), por vía de administración (oral, intravenosa, subcutánea), por grupo de edad del paciente (pediátrico, adulto, geriátrico), por canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea) y por región (América del Norte, Europa, América del Sur, Asia Pacífico, Medio Oriente y África): pronóstico para 2034
Las empresas clave en el mercado Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market incluyen
Alcance del informe
FAQs
What is the projected market valuation for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market by 2035?
The projected market valuation for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market is 2.434 USD Billion by 2035.
What was the market valuation for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market in 2024?
The market valuation for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market was 0.6234 USD Billion in 2024.
What is the expected CAGR for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market during the forecast period 2025 - 2035?
The expected CAGR for the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market during the forecast period 2025 - 2035 is 13.18%.
Which companies are considered key players in the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market?
Key players in the market include Sobi AB, Eisai Co Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., Roche Holding AG, AstraZeneca PLC, and Takeda Pharmaceutical Company Limited.
What are the main segments of the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market?
The main segments of the market include Type, Route of Administration, Patient Age Group, and Distribution Channel.
What was the market size for Medication in the Gamma-Aminobutyric Acid Transaminase Deficiency Treatment Market in 2024?
The market size for Medication in 2024 was 0.2494 USD Billion.
What is the projected market size for Dietary Management by 2035?
The projected market size for Dietary Management is 0.7153 USD Billion by 2035.
How does the market size for Adult patients compare to Geriatric patients in 2024?
In 2024, the market size for Adult patients was 0.2491 USD Billion, whereas for Geriatric patients, it was 0.1879 USD Billion.
What is the expected market size for Online Pharmacy distribution by 2035?
The expected market size for Online Pharmacy distribution is 0.7144 USD Billion by 2035.
What was the market size for Intravenous administration in 2024?
The market size for Intravenous administration in 2024 was 0.1865 USD Billion.
Descargar muestra gratis
Complete el formulario a continuación para recibir una muestra gratuita de este informe
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Estudio de caso
Aerospace & Defense
Deja un comentario